Can a blood test change how doctors treat Alzheimer's? new study investigates

NCT ID NCT07099001

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving doctors educational materials about a new blood test for Alzheimer's disease helps them make better care decisions. 178 neurologists and dementia specialists in the US participated in virtual patient cases. The researchers measured changes in diagnosis and treatment recommendations after doctors received the educational materials and test results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that educating doctors about a new blood test improves how they diagnose and manage Alzheimer's disease.

What could go wrong

This is a small, completed study using virtual patients, not real ones. The results may not reflect how doctors would act in actual clinical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE DECLINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • QURE Healthcare

    St Louis, Missouri, 63110, United States